We are live on
!
Find out more
JA
JLB & Associates Portfolio holdings
AUM
$696M
1-Year Est. Return
17.86%
This Fund
S&P 500
This Quarter
Est. Return
+2.24%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
–
AUM
$279M
AUM Growth
+$3.52M
(+1.3%)
Cap. Flow
-$502K
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
30.61%
Holding
75
New
1
Increased
23
Reduced
42
Closed
–
Top Buys
| 1 |
Keurig Dr Pepper
KDP
|
+$764K |
| 2 |
Packaging Corp of America
PKG
|
+$527K |
| 3 |
EV
Eaton Vance Corp.
EV
|
+$267K |
| 4 |
Global Payments
GPN
|
+$261K |
| 5 |
Advance Auto Parts
AAP
|
+$251K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
+$716K |
| 2 |
Expeditors International
EXPD
|
+$651K |
| 3 |
ALTR
Altera Corp
ALTR
|
+$454K |
| 4 |
Flowserve
FLS
|
+$337K |
| 5 |
Abbott
ABT
|
+$271K |
Sector Composition
| 1 | Technology | 18.84% |
| 2 | Healthcare | 16.98% |
| 3 | Consumer Discretionary | 16.76% |
| 4 | Industrials | 13.7% |
| 5 | Consumer Staples | 11.21% |
Similar funds
AAM
CA
CA
FCM
GUB
AWC
BBPWM
SCM
JLB & Associates's Q3 2014 Portfolio in Review
As of Q3 2014, JLB & Associates held 75 positions worth $279M, up 1.3% from $275M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 1.3%. JLB & Associates opened 1 new position and made no exits, leaving the 75-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JLB & Associates's largest Q3 2014 buy was Packaging Corp of America: 7,851 shares worth $501K.
- JLB & Associates added most to Keurig Dr Pepper in Q3 2014, an estimated $764K increase.
- JLB & Associates's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $716K.
- JLB & Associates's ten largest holdings make up 31% of its $279M portfolio in Q3 2014.
- JLB & Associates opened 1 new position and closed 0 in Q3 2014.
- JLB & Associates's portfolio value rose 1.3% quarter-over-quarter to $279M.
Based on JLB & Associates's 13F filing for Q3 2014, filed 7 Oct 2014.